Regulation of Sugar Transport and Metabolism in Lactic Acid and Oral Bacteria
Regulation of Sugar Transport and Metabolism in Lactic Acid and Oral Bacteria
批准号:
6432004
负责人:
JOHN M THOMPSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Fusobacterium Lactobacillus O glycosidase Streptococcus active sites bacterial genetics bacterial proteins carbohydrate metabolism carbohydrate transport genetic markers genetic promoter element hydrolase lactates maltose microorganism culture microorganism metabolism molecular cloning nucleic acid sequence oral bacteria plasmids sugar phosphates transfection transposon /insertion element
中文摘要
膳食中的蔗糖是口腔细菌致病性的主要因素。例如,在龋齿的病因学中:(1)蔗糖为多糖的合成提供了基础,从而促进了链球菌物种对牙齿表面的粘附;(2)糖的细菌发酵产生乳酸,导致牙釉质脱矿。蔗糖本身由葡萄糖和果糖分子组成,它们连接在前者的碳原子1和后者的碳原子2之间。蔗糖在转运到细菌的同时被磷酸化,随后被一种称为蔗糖6-磷酸水解酶(S6PH)的酶水解。葡萄糖的C1和果糖的剩余五个碳原子之间的交替键产生五种蔗糖类似物,分别是海藻糖(1-1)、葡聚糖(1-3)、麦芽糖(1-4)、亮糖(1-5)和巴丁糖(1-6)。值得注意的是,这些同分异构体化合物(与天然双糖相反)不支持口服链球菌的生长。重要的是,这些相对甜的类似物中的两种,帕丁糖和亮糖,已经在工业规模上生产,由于它们的无龋齿性,是膳食蔗糖的潜在替代品。为什么像变形链球菌这样的生物体不能代谢蔗糖异构体,这是我们最近研究的一个话题。过去一年的两项主要成就包括首次生物合成蔗糖的所有五种磷酸化异构体,以及证明S6PH不能催化任何这些磷酸化衍生物的水解。这是我们的论点,微妙的构象差异,在紧凑的球形蔗糖分子和线性扩展形式的异构体之间,是基础的底物区分的S6PH。由此推论,我们的发现为合理合成蔗糖类似物提供了见解,通过灭活S6PH,可以选择性靶向和抑制诱导龋齿细菌的生长。
英文摘要
Dietary sucrose is a major contributor to pathogenicity of oral bacteria. For example, in the etiology of dental caries : (1) sucrose provides the building blocks for synthesis of glycans that facilitate adherence of Streptococcal species to the tooth surface, and (2) bacterial fermentation of the sugar generates lactic acid that causes demineralization of tooth enamel. Sucrose itself comprises glucose and fructose molecules that are linked between carbon atom 1 of the former and carbon atom 2 of the latter. Sucrose is phosphorylated simultaneously with transport into the bacteria, where it is subsequently hydrolyzed by an enzyme designated sucrose 6-phosphate hydrolase (S6PH). Alternate linkages between C1 of glucose and the remaining five carbon atoms of fructose yield five analogs of sucrose designated trehalulose (1-1), turanose (1-3), maltulose (1-4), leucrose (1-5) and palatinose (1-6). Remarkably, these isomeric compounds (in contrast to the natural disaccharide) do not support growth of oral streptococci. Importantly, two of these relatively sweet analogs, palatinose and leucrose, are produced on an industrial scale and - by virtue of their non-cariogenicity - are potential substitutes for dietary sucrose. Why organisms such as Streptococcus mutans fail to metabolize the sucrose isomers has never been established, and is a topic that we have recently addressed. Two major accomplishments of the past year include the first biosynthesis of all five phosphorylated isomers of sucrose, and the demonstration that S6PH is unable to catalyze the hydrolysis of any of these phosphorylated derivatives. It is our contention that subtle conformational differences, between the compact globular sucrose molecule and the linearly extended forms of the isomers, are the basis for substrate discrimination by S6PH. By corollary, our findings provide insight to the rational synthesis of sucrose analogs that - by inactivating S6PH - may permit selective targeting and inhibition of growth of caries-inducing bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF SUGAR TRANSPORT AND METABOLISM IN LACTIC ACID AND ORAL BACTERIA
-
批准号:6289665
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JOHN M THOMPSON
-
依托单位:
Regulation Of Sugar Transport And Metabolism In Lactic A
-
批准号:6675534
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JOHN M THOMPSON
-
依托单位:
Sugar Transport /Metabolism In Lactic Acid & oral Bacter
-
批准号:6814426
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JOHN M THOMPSON
-
依托单位:
Sugar Metabolism In Lactic Acid and Oral Bacteria
-
批准号:6507129
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JOHN M THOMPSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
瘤内细菌 Lactobacillus iners 通过
eIF4A2 乳酸化介导肿瘤相关巨噬细胞极
化诱导膀胱癌免疫化疗抵抗的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:吴志明
-
依托单位:
肠道菌群Lactobacillus来源的吲哚-3-
甲醛对绝经后骨量丢失的保护机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:庄景燊
-
依托单位:
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邱敬诚
-
依托单位:
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
-
批准号:82305009
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王文波
-
依托单位:
草苁蓉介导的肠道Lactobacillus reuteri菌通过长链脂肪酸调控糖脂代谢改善2型糖尿病的作用机制
-
批准号:32260026
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:全林虎
-
依托单位:
Lactobacillus plantarum CQPC05通过细胞凋亡通路干预结直肠癌的效果
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:余婷
-
依托单位:
基于肠道菌群-免疫轴解析Lactobacillus murinus 0516抗鸡传染性支气管炎病毒感染的机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:尹海畅
-
依托单位:
荔枝黄酮QRR与原花青素A2协同增殖肠道Akkermansia和Lactobacillus菌保护肠粘膜屏障机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:苏东晓
-
依托单位:
猪肠道细菌Lactobacillus gasseri LA39调控胆汁酸代谢的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
益生菌Lactobacillus plantarum HNU082在宿主肠道内适应性进化机制研究
-
批准号:32160545
-
项目类别:地区科学基金项目
-
资助金额:36万元
-
批准年份:2021
-
负责人:张家超
-
依托单位: